Can blood-based Alzheimer’s diagnostics change clinical practice? C2N Diagnostics enters South Korea with PrecivityAD2
C2N Diagnostics brings its PrecivityAD2 blood test to South Korea through BeauBrain Healthcare. Discover what this means for Alzheimer’s diagnosis.